Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Specimen Handling 149pembrolizumab 123Magnetic Resonance Spectroscopy 120Cyclophosphamide 115Biopsy 98fludarabine 90Nivolumab 53Carboplatin 53Cisplatin 48Gemcitabine 46Radiotherapy 41venetoclax 40fludarabine phosphate 40Paclitaxel 40Cetuximab 40Ipilimumab 34atezolizumab 33Fluorouracil 33Bevacizumab 33Oxaliplatin 27Leucovorin 27X-Rays 26Dexamethasone 26durvalumab 25Irinotecan 25Radiation 24Cytarabine 24Azacitidine 24Injections 23Pemetrexed 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × small molecule inhibitor THX-B × 90 days × Clear all
NCT05694715 2026-03-17

Combination Therapy in Cancers With Mutations in DNA Repair Genes

University of California, San Francisco

Phase 1 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡